# OnCo record bradley-monk (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/bradley-monk/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "bradley-monk" ;
  schema:name "Bradley J. Monk"@en ;
  schema:description "Gynaecologic oncologist who co-led KEYNOTE-826, innovaTV 301 and KEYNOTE-A18, the trials that rebuilt cervical cancer treatment."@en ;
  schema:url <https://onco.cc/people/bradley-monk/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bradley_J._Monk> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Monk%20BJ%5BAuthor%5D%20cervical> ;
  onco:tag "cervical", "ovarian", "cooperative-group" ;
  schema:jobTitle "Gynecologic Oncologist, Florida Cancer Specialists; Professor, University of Arizona and Creighton University; Co-Director, GOG Partners" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/tissue-factor/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/tisotumab-vedotin/> ;
  onco:trials <https://onco.cc/trials/keynote-826/>, <https://onco.cc/trials/innovatv-301/>, <https://onco.cc/trials/keynote-a18/>, <https://onco.cc/trials/athena-mono/> .